Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02501044 · ClinicalTrials.gov registry record
Oxygen Desaturation During Hemodialysis
A clinical trial, sponsored by Renal Research Institute.
- Completed
- Registry status
- 5,500
- Enrollment target
NCT02501044 is a clinical trial that has completed, run by Renal Research Institute. The registered enrollment target is 5,500 participants.
The verdict
NCT02501044 has completed, sponsored by Renal Research Institute.
- COMPLETED
- Registry status
- 5,500 participants
- Enrollment target
Study Summary
Hemodialysis patients may experience drops in blood oxygen saturation during the hemodialysis treatment, which may lead to hypoxia in the tissues. The investigators hypothesize that: 1. The cumulative number, severity, or other characteristics of such deoxygenation episodes may be a predictor of adverse outcomes in hemodialysis patients. 2. There may be demographic, anthropometric, clinical, treatment prescription, lab analytical, and other parameters that correlate with the number and severity of deoxygenation episodes and, therefore, may be used for risk stratification. Further, some of these parameters may be modifiable.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,500 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02501044
The ClinicalTrials.gov registry entry for NCT02501044 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Renal Research Institute, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02501044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02501044 about?
NCT02501044 is a clinical study titled "Oxygen Desaturation During Hemodialysis". Hemodialysis patients may experience drops in blood oxygen saturation during the hemodialysis treatment, which may lead to hypoxia in the tissues. The investigators hypothesize that: 1. The cumulative number, severity, or other characteristics of such deoxygenation episodes may be a predictor of a...
What is the current status of trial NCT02501044?
This trial is currently completed. The enrollment target is 5,500 participants. The study started on 2012-01. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT02501044?
This trial is sponsored by Renal Research Institute, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.